Europe To Establish Emergency Biodefense Plan To Respond To Coronavirus Variants – More Local Manufacturing For Rapid Scale Up Of New Vaccines & Boosters 17/02/2021 Svĕt Lustig Vijay The European Commission will establish an emergency biodefense plan to prevent, mitigate and respond to new variants of the coronavirus that are supercharging transmission and threatening the performance of available vaccines. Creation of a voluntary licensing mechanism involving local manufacturers is one of the strategies proposed in the plan to hasten the production of updated […] Continue reading -> WHO Experts Recommend AstraZeneca COVID Vaccine Across All Ages & Countries – Signal For Start Of Global COVAX Vaccine Rollout 10/02/2021 Elaine Ruth Fletcher A World Health Organization expert group has recommended the use of the AstraZeneca two-dose COVID-19 vaccine for use in countries worldwide – and among groups including people over the age of 65. The sweeping recommendation by WHO “Strategic Advisory Group of Experts” (SAGE) marks what WHO Chief Scientist Soumya Swaminathan described as an “important milestone” […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> Uganda Defends Price Paid For AstraZeneca COVID19 Vaccine; New Study Suggests Vaccine Could Cut Transmission By Two-Thirds 03/02/2021 Esther Nakkazi KAMPALA, UGANDA – Responding to a swell of global criticism, a senior Ugandan health official told Health Policy Watch that Uganda’s government is not paying unreasonably higher prices for it’s AstraZeneca vaccines, in comparison to other African countries – or Europe. “You cannot compare prices directly between countries because there are many factors to consider. […] Continue reading -> Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed Trial Results 02/02/2021 Svĕt Lustig Vijay Fulfilling the legacy of its pioneering name, the Russian Sputnik V vaccine, was over 91% effective in preventing symptomatic COVID-19 cases and 100% effective in preventing severe COVID, according to results published Tuesday in The Lancet. Globally, that means that the Sputnik vaccine joins the club with just two other coronavirus vaccines that have demonstrated […] Continue reading -> COVID-19 Has Outlined Healthcare Systems’ Dangerous Emissions Problem 29/01/2021 Raisa Santos Failure to align the global recovery from COVID-19 with an equally powerful climate response could threaten the worldwide effort to limit the average global temperature increase, public health experts have said. In a convention in 2015 now known as the Paris Agreement, the United Nations Framework Convention on Climate Change (UNFCCC) established its aim to […] Continue reading -> Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> Israel’s Massive Immunization Campaign Pricked By Soaring COVID-19 Infections 20/01/2021 Elaine Ruth Fletcher JERUSALEM – As the countries around the globe watch Israel’s massive COVID-19 vaccine rollout to see if it can really beat back the virus, once soaring hopes that vaccines, on their own, could offer an easy way out of the pandemic are now coming back down to ground. On the positive side, the vaccine itself […] Continue reading -> European Medicines Agency and Swissmedic Approve Pfizer’s COVID-19 Vaccine – Positioning Europe To Start Immunizations On Heels Of US, Canada, UK and Israel 21/12/2020 Elaine Ruth Fletcher The European Medicines Agency (EMA) announced on Monday that it would recommend conditional marketing authorization for the Pfizer/BioNTech COVID-19 vaccine – positioning Europe to finally begin rolling out vaccines across the continent – albeit after the United States, Canada, the United Kingdom and Israel have already moved into high gear vaccine campaigns. Mass vaccinations were […] Continue reading -> First Ever Peer-Reviewed COVID-19 Vaccine Trial Results – The Oxford Vaccine 08/12/2020 Svĕt Lustig Vijay Just hours after the UK jabbed its first citizen against the coronavirus, researchers have confirmed that Oxford’s vaccine is safe and effective in the first peer-reviewed publication of a Phase III coronavirus vaccine trial yet. “The results for me are very compelling,” said AstraZeneca’s executive vice president Mene Pangalos on Wednesday at a press conference. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Experts Recommend AstraZeneca COVID Vaccine Across All Ages & Countries – Signal For Start Of Global COVAX Vaccine Rollout 10/02/2021 Elaine Ruth Fletcher A World Health Organization expert group has recommended the use of the AstraZeneca two-dose COVID-19 vaccine for use in countries worldwide – and among groups including people over the age of 65. The sweeping recommendation by WHO “Strategic Advisory Group of Experts” (SAGE) marks what WHO Chief Scientist Soumya Swaminathan described as an “important milestone” […] Continue reading -> Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> Uganda Defends Price Paid For AstraZeneca COVID19 Vaccine; New Study Suggests Vaccine Could Cut Transmission By Two-Thirds 03/02/2021 Esther Nakkazi KAMPALA, UGANDA – Responding to a swell of global criticism, a senior Ugandan health official told Health Policy Watch that Uganda’s government is not paying unreasonably higher prices for it’s AstraZeneca vaccines, in comparison to other African countries – or Europe. “You cannot compare prices directly between countries because there are many factors to consider. […] Continue reading -> Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed Trial Results 02/02/2021 Svĕt Lustig Vijay Fulfilling the legacy of its pioneering name, the Russian Sputnik V vaccine, was over 91% effective in preventing symptomatic COVID-19 cases and 100% effective in preventing severe COVID, according to results published Tuesday in The Lancet. Globally, that means that the Sputnik vaccine joins the club with just two other coronavirus vaccines that have demonstrated […] Continue reading -> COVID-19 Has Outlined Healthcare Systems’ Dangerous Emissions Problem 29/01/2021 Raisa Santos Failure to align the global recovery from COVID-19 with an equally powerful climate response could threaten the worldwide effort to limit the average global temperature increase, public health experts have said. In a convention in 2015 now known as the Paris Agreement, the United Nations Framework Convention on Climate Change (UNFCCC) established its aim to […] Continue reading -> Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> Israel’s Massive Immunization Campaign Pricked By Soaring COVID-19 Infections 20/01/2021 Elaine Ruth Fletcher JERUSALEM – As the countries around the globe watch Israel’s massive COVID-19 vaccine rollout to see if it can really beat back the virus, once soaring hopes that vaccines, on their own, could offer an easy way out of the pandemic are now coming back down to ground. On the positive side, the vaccine itself […] Continue reading -> European Medicines Agency and Swissmedic Approve Pfizer’s COVID-19 Vaccine – Positioning Europe To Start Immunizations On Heels Of US, Canada, UK and Israel 21/12/2020 Elaine Ruth Fletcher The European Medicines Agency (EMA) announced on Monday that it would recommend conditional marketing authorization for the Pfizer/BioNTech COVID-19 vaccine – positioning Europe to finally begin rolling out vaccines across the continent – albeit after the United States, Canada, the United Kingdom and Israel have already moved into high gear vaccine campaigns. Mass vaccinations were […] Continue reading -> First Ever Peer-Reviewed COVID-19 Vaccine Trial Results – The Oxford Vaccine 08/12/2020 Svĕt Lustig Vijay Just hours after the UK jabbed its first citizen against the coronavirus, researchers have confirmed that Oxford’s vaccine is safe and effective in the first peer-reviewed publication of a Phase III coronavirus vaccine trial yet. “The results for me are very compelling,” said AstraZeneca’s executive vice president Mene Pangalos on Wednesday at a press conference. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Publication Of Sputnik V Results Shore Up Prospects Of “Elusive Trio” – But Answers Still Needed On China’s COVID-19 Vaccines 04/02/2021 Svĕt Lustig Vijay & Vijay Shankar Balakrishnan News of the successful trial results of the Russian Sputnik vaccine, published on Wednesday by The Lancet has shored up the prospects of quick vaccine access for dozens of countries that have pinned their hopes on Russian or Chinese vaccine alternatives – as rich countries buy up the bulk of supplies of high-tech vaccines and […] Continue reading -> Uganda Defends Price Paid For AstraZeneca COVID19 Vaccine; New Study Suggests Vaccine Could Cut Transmission By Two-Thirds 03/02/2021 Esther Nakkazi KAMPALA, UGANDA – Responding to a swell of global criticism, a senior Ugandan health official told Health Policy Watch that Uganda’s government is not paying unreasonably higher prices for it’s AstraZeneca vaccines, in comparison to other African countries – or Europe. “You cannot compare prices directly between countries because there are many factors to consider. […] Continue reading -> Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed Trial Results 02/02/2021 Svĕt Lustig Vijay Fulfilling the legacy of its pioneering name, the Russian Sputnik V vaccine, was over 91% effective in preventing symptomatic COVID-19 cases and 100% effective in preventing severe COVID, according to results published Tuesday in The Lancet. Globally, that means that the Sputnik vaccine joins the club with just two other coronavirus vaccines that have demonstrated […] Continue reading -> COVID-19 Has Outlined Healthcare Systems’ Dangerous Emissions Problem 29/01/2021 Raisa Santos Failure to align the global recovery from COVID-19 with an equally powerful climate response could threaten the worldwide effort to limit the average global temperature increase, public health experts have said. In a convention in 2015 now known as the Paris Agreement, the United Nations Framework Convention on Climate Change (UNFCCC) established its aim to […] Continue reading -> Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> Israel’s Massive Immunization Campaign Pricked By Soaring COVID-19 Infections 20/01/2021 Elaine Ruth Fletcher JERUSALEM – As the countries around the globe watch Israel’s massive COVID-19 vaccine rollout to see if it can really beat back the virus, once soaring hopes that vaccines, on their own, could offer an easy way out of the pandemic are now coming back down to ground. On the positive side, the vaccine itself […] Continue reading -> European Medicines Agency and Swissmedic Approve Pfizer’s COVID-19 Vaccine – Positioning Europe To Start Immunizations On Heels Of US, Canada, UK and Israel 21/12/2020 Elaine Ruth Fletcher The European Medicines Agency (EMA) announced on Monday that it would recommend conditional marketing authorization for the Pfizer/BioNTech COVID-19 vaccine – positioning Europe to finally begin rolling out vaccines across the continent – albeit after the United States, Canada, the United Kingdom and Israel have already moved into high gear vaccine campaigns. Mass vaccinations were […] Continue reading -> First Ever Peer-Reviewed COVID-19 Vaccine Trial Results – The Oxford Vaccine 08/12/2020 Svĕt Lustig Vijay Just hours after the UK jabbed its first citizen against the coronavirus, researchers have confirmed that Oxford’s vaccine is safe and effective in the first peer-reviewed publication of a Phase III coronavirus vaccine trial yet. “The results for me are very compelling,” said AstraZeneca’s executive vice president Mene Pangalos on Wednesday at a press conference. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Uganda Defends Price Paid For AstraZeneca COVID19 Vaccine; New Study Suggests Vaccine Could Cut Transmission By Two-Thirds 03/02/2021 Esther Nakkazi KAMPALA, UGANDA – Responding to a swell of global criticism, a senior Ugandan health official told Health Policy Watch that Uganda’s government is not paying unreasonably higher prices for it’s AstraZeneca vaccines, in comparison to other African countries – or Europe. “You cannot compare prices directly between countries because there are many factors to consider. […] Continue reading -> Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed Trial Results 02/02/2021 Svĕt Lustig Vijay Fulfilling the legacy of its pioneering name, the Russian Sputnik V vaccine, was over 91% effective in preventing symptomatic COVID-19 cases and 100% effective in preventing severe COVID, according to results published Tuesday in The Lancet. Globally, that means that the Sputnik vaccine joins the club with just two other coronavirus vaccines that have demonstrated […] Continue reading -> COVID-19 Has Outlined Healthcare Systems’ Dangerous Emissions Problem 29/01/2021 Raisa Santos Failure to align the global recovery from COVID-19 with an equally powerful climate response could threaten the worldwide effort to limit the average global temperature increase, public health experts have said. In a convention in 2015 now known as the Paris Agreement, the United Nations Framework Convention on Climate Change (UNFCCC) established its aim to […] Continue reading -> Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> Israel’s Massive Immunization Campaign Pricked By Soaring COVID-19 Infections 20/01/2021 Elaine Ruth Fletcher JERUSALEM – As the countries around the globe watch Israel’s massive COVID-19 vaccine rollout to see if it can really beat back the virus, once soaring hopes that vaccines, on their own, could offer an easy way out of the pandemic are now coming back down to ground. On the positive side, the vaccine itself […] Continue reading -> European Medicines Agency and Swissmedic Approve Pfizer’s COVID-19 Vaccine – Positioning Europe To Start Immunizations On Heels Of US, Canada, UK and Israel 21/12/2020 Elaine Ruth Fletcher The European Medicines Agency (EMA) announced on Monday that it would recommend conditional marketing authorization for the Pfizer/BioNTech COVID-19 vaccine – positioning Europe to finally begin rolling out vaccines across the continent – albeit after the United States, Canada, the United Kingdom and Israel have already moved into high gear vaccine campaigns. Mass vaccinations were […] Continue reading -> First Ever Peer-Reviewed COVID-19 Vaccine Trial Results – The Oxford Vaccine 08/12/2020 Svĕt Lustig Vijay Just hours after the UK jabbed its first citizen against the coronavirus, researchers have confirmed that Oxford’s vaccine is safe and effective in the first peer-reviewed publication of a Phase III coronavirus vaccine trial yet. “The results for me are very compelling,” said AstraZeneca’s executive vice president Mene Pangalos on Wednesday at a press conference. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Russia’s “Sputnik V” COVID Vaccine Makes Strong 91.6 % Efficacy Showing In Peer-Reviewed Trial Results 02/02/2021 Svĕt Lustig Vijay Fulfilling the legacy of its pioneering name, the Russian Sputnik V vaccine, was over 91% effective in preventing symptomatic COVID-19 cases and 100% effective in preventing severe COVID, according to results published Tuesday in The Lancet. Globally, that means that the Sputnik vaccine joins the club with just two other coronavirus vaccines that have demonstrated […] Continue reading -> COVID-19 Has Outlined Healthcare Systems’ Dangerous Emissions Problem 29/01/2021 Raisa Santos Failure to align the global recovery from COVID-19 with an equally powerful climate response could threaten the worldwide effort to limit the average global temperature increase, public health experts have said. In a convention in 2015 now known as the Paris Agreement, the United Nations Framework Convention on Climate Change (UNFCCC) established its aim to […] Continue reading -> Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> Israel’s Massive Immunization Campaign Pricked By Soaring COVID-19 Infections 20/01/2021 Elaine Ruth Fletcher JERUSALEM – As the countries around the globe watch Israel’s massive COVID-19 vaccine rollout to see if it can really beat back the virus, once soaring hopes that vaccines, on their own, could offer an easy way out of the pandemic are now coming back down to ground. On the positive side, the vaccine itself […] Continue reading -> European Medicines Agency and Swissmedic Approve Pfizer’s COVID-19 Vaccine – Positioning Europe To Start Immunizations On Heels Of US, Canada, UK and Israel 21/12/2020 Elaine Ruth Fletcher The European Medicines Agency (EMA) announced on Monday that it would recommend conditional marketing authorization for the Pfizer/BioNTech COVID-19 vaccine – positioning Europe to finally begin rolling out vaccines across the continent – albeit after the United States, Canada, the United Kingdom and Israel have already moved into high gear vaccine campaigns. Mass vaccinations were […] Continue reading -> First Ever Peer-Reviewed COVID-19 Vaccine Trial Results – The Oxford Vaccine 08/12/2020 Svĕt Lustig Vijay Just hours after the UK jabbed its first citizen against the coronavirus, researchers have confirmed that Oxford’s vaccine is safe and effective in the first peer-reviewed publication of a Phase III coronavirus vaccine trial yet. “The results for me are very compelling,” said AstraZeneca’s executive vice president Mene Pangalos on Wednesday at a press conference. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
COVID-19 Has Outlined Healthcare Systems’ Dangerous Emissions Problem 29/01/2021 Raisa Santos Failure to align the global recovery from COVID-19 with an equally powerful climate response could threaten the worldwide effort to limit the average global temperature increase, public health experts have said. In a convention in 2015 now known as the Paris Agreement, the United Nations Framework Convention on Climate Change (UNFCCC) established its aim to […] Continue reading -> Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> Israel’s Massive Immunization Campaign Pricked By Soaring COVID-19 Infections 20/01/2021 Elaine Ruth Fletcher JERUSALEM – As the countries around the globe watch Israel’s massive COVID-19 vaccine rollout to see if it can really beat back the virus, once soaring hopes that vaccines, on their own, could offer an easy way out of the pandemic are now coming back down to ground. On the positive side, the vaccine itself […] Continue reading -> European Medicines Agency and Swissmedic Approve Pfizer’s COVID-19 Vaccine – Positioning Europe To Start Immunizations On Heels Of US, Canada, UK and Israel 21/12/2020 Elaine Ruth Fletcher The European Medicines Agency (EMA) announced on Monday that it would recommend conditional marketing authorization for the Pfizer/BioNTech COVID-19 vaccine – positioning Europe to finally begin rolling out vaccines across the continent – albeit after the United States, Canada, the United Kingdom and Israel have already moved into high gear vaccine campaigns. Mass vaccinations were […] Continue reading -> First Ever Peer-Reviewed COVID-19 Vaccine Trial Results – The Oxford Vaccine 08/12/2020 Svĕt Lustig Vijay Just hours after the UK jabbed its first citizen against the coronavirus, researchers have confirmed that Oxford’s vaccine is safe and effective in the first peer-reviewed publication of a Phase III coronavirus vaccine trial yet. “The results for me are very compelling,” said AstraZeneca’s executive vice president Mene Pangalos on Wednesday at a press conference. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Interview with Björn Kümmel, Vice Chair, WHO Executive Board 26/01/2021 Priti Patnaik Discussions on WHO’s state of financing were addressed by member states during the on-going Executive Board meeting. As we reported last week, WHO is keen on defining independence and sustainability of its financing to be better prepared to address emergencies in the future. We spoke to Björn Kümmel, Deputy Head of Unit, Global Health, German Federal Ministry […] Continue reading -> Israel’s Massive Immunization Campaign Pricked By Soaring COVID-19 Infections 20/01/2021 Elaine Ruth Fletcher JERUSALEM – As the countries around the globe watch Israel’s massive COVID-19 vaccine rollout to see if it can really beat back the virus, once soaring hopes that vaccines, on their own, could offer an easy way out of the pandemic are now coming back down to ground. On the positive side, the vaccine itself […] Continue reading -> European Medicines Agency and Swissmedic Approve Pfizer’s COVID-19 Vaccine – Positioning Europe To Start Immunizations On Heels Of US, Canada, UK and Israel 21/12/2020 Elaine Ruth Fletcher The European Medicines Agency (EMA) announced on Monday that it would recommend conditional marketing authorization for the Pfizer/BioNTech COVID-19 vaccine – positioning Europe to finally begin rolling out vaccines across the continent – albeit after the United States, Canada, the United Kingdom and Israel have already moved into high gear vaccine campaigns. Mass vaccinations were […] Continue reading -> First Ever Peer-Reviewed COVID-19 Vaccine Trial Results – The Oxford Vaccine 08/12/2020 Svĕt Lustig Vijay Just hours after the UK jabbed its first citizen against the coronavirus, researchers have confirmed that Oxford’s vaccine is safe and effective in the first peer-reviewed publication of a Phase III coronavirus vaccine trial yet. “The results for me are very compelling,” said AstraZeneca’s executive vice president Mene Pangalos on Wednesday at a press conference. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Israel’s Massive Immunization Campaign Pricked By Soaring COVID-19 Infections 20/01/2021 Elaine Ruth Fletcher JERUSALEM – As the countries around the globe watch Israel’s massive COVID-19 vaccine rollout to see if it can really beat back the virus, once soaring hopes that vaccines, on their own, could offer an easy way out of the pandemic are now coming back down to ground. On the positive side, the vaccine itself […] Continue reading -> European Medicines Agency and Swissmedic Approve Pfizer’s COVID-19 Vaccine – Positioning Europe To Start Immunizations On Heels Of US, Canada, UK and Israel 21/12/2020 Elaine Ruth Fletcher The European Medicines Agency (EMA) announced on Monday that it would recommend conditional marketing authorization for the Pfizer/BioNTech COVID-19 vaccine – positioning Europe to finally begin rolling out vaccines across the continent – albeit after the United States, Canada, the United Kingdom and Israel have already moved into high gear vaccine campaigns. Mass vaccinations were […] Continue reading -> First Ever Peer-Reviewed COVID-19 Vaccine Trial Results – The Oxford Vaccine 08/12/2020 Svĕt Lustig Vijay Just hours after the UK jabbed its first citizen against the coronavirus, researchers have confirmed that Oxford’s vaccine is safe and effective in the first peer-reviewed publication of a Phase III coronavirus vaccine trial yet. “The results for me are very compelling,” said AstraZeneca’s executive vice president Mene Pangalos on Wednesday at a press conference. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
European Medicines Agency and Swissmedic Approve Pfizer’s COVID-19 Vaccine – Positioning Europe To Start Immunizations On Heels Of US, Canada, UK and Israel 21/12/2020 Elaine Ruth Fletcher The European Medicines Agency (EMA) announced on Monday that it would recommend conditional marketing authorization for the Pfizer/BioNTech COVID-19 vaccine – positioning Europe to finally begin rolling out vaccines across the continent – albeit after the United States, Canada, the United Kingdom and Israel have already moved into high gear vaccine campaigns. Mass vaccinations were […] Continue reading -> First Ever Peer-Reviewed COVID-19 Vaccine Trial Results – The Oxford Vaccine 08/12/2020 Svĕt Lustig Vijay Just hours after the UK jabbed its first citizen against the coronavirus, researchers have confirmed that Oxford’s vaccine is safe and effective in the first peer-reviewed publication of a Phase III coronavirus vaccine trial yet. “The results for me are very compelling,” said AstraZeneca’s executive vice president Mene Pangalos on Wednesday at a press conference. […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
First Ever Peer-Reviewed COVID-19 Vaccine Trial Results – The Oxford Vaccine 08/12/2020 Svĕt Lustig Vijay Just hours after the UK jabbed its first citizen against the coronavirus, researchers have confirmed that Oxford’s vaccine is safe and effective in the first peer-reviewed publication of a Phase III coronavirus vaccine trial yet. “The results for me are very compelling,” said AstraZeneca’s executive vice president Mene Pangalos on Wednesday at a press conference. […] Continue reading -> Posts navigation Older postsNewer posts